share_log

Veracyte Analyst Ratings

Veracyte Analyst Ratings

Veracyte 分析师评级
Benzinga ·  2023/10/23 09:06
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/23/2023 52.89% Goldman Sachs $37 → $32 Maintains Buy
10/20/2023 52.89% Goldman Sachs $37 → $32 Maintains Buy
10/10/2023 62.45% Stephens & Co. → $34 Reiterates Overweight → Overweight
08/09/2023 9.89% Morgan Stanley $22 → $23 Maintains Underweight
08/09/2023 67.22% Needham $34 → $35 Maintains Buy
05/08/2023 43.33% Stephens & Co. → $30 Reiterates → Overweight
02/23/2023 62.45% Needham $33 → $34 Maintains Buy
01/18/2023 — Raymond James Downgrades Outperform → Market Perform
01/05/2023 57.67% Scotiabank → $33 Initiates Coverage On → Sector Outperform
11/04/2022 5.11% Morgan Stanley $23 → $22 Maintains Underweight
11/04/2022 29% Raymond James $31 → $27 Maintains Outperform
11/03/2022 57.67% Needham $31 → $33 Maintains Buy
11/03/2022 67.22% SVB Leerink $30 → $35 Maintains Outperform
08/04/2022 48.11% Raymond James $30 → $31 Maintains Outperform
08/03/2022 48.11% Needham $26 → $31 Maintains Buy
05/05/2022 43.33% Stephens & Co. $44 → $30 Maintains Overweight
05/04/2022 9.89% Morgan Stanley $25 → $23 Maintains Underweight
05/04/2022 43.33% Raymond James $34 → $30 Maintains Outperform
05/04/2022 24.22% Needham $31 → $26 Maintains Buy
03/15/2022 48.11% Needham $35 → $31 Maintains Buy
03/02/2022 110.22% Stephens & Co. $52 → $44 Maintains Overweight
03/01/2022 62.45% Raymond James $62 → $34 Maintains Outperform
03/01/2022 91.11% SVB Leerink $45 → $40 Maintains Outperform
01/07/2022 148.45% Stephens & Co. → $52 Initiates Coverage On → Overweight
11/10/2021 196.23% Raymond James $50 → $62 Maintains Outperform
07/30/2021 100.67% Morgan Stanley $45 → $42 Maintains Underweight
07/30/2021 162.78% Needham $54 → $55 Maintains Buy
07/30/2021 186.67% SVB Leerink $55 → $60 Maintains Outperform
07/14/2021 162.78% SVB Leerink $65 → $55 Maintains Outperform
06/28/2021 138.89% Raymond James $45 → $50 Maintains Outperform
06/15/2021 115% Raymond James → $45 Initiates Coverage On → Outperform
05/18/2021 162.78% Truist Securities $84 → $55 Maintains Buy
05/12/2021 115% Morgan Stanley $65 → $45 Maintains Underweight
05/11/2021 210.56% SVB Leerink $75 → $65 Maintains Outperform
05/11/2021 158% Needham $88 → $54 Maintains Buy
02/22/2021 210.56% Morgan Stanley $35 → $65 Maintains Underweight
02/19/2021 210.56% Morgan Stanley $35 → $65 Maintains Underweight
02/18/2021 306.12% SVB Leerink $83 → $85 Maintains Outperform
02/08/2021 296.56% SVB Leerink $40 → $83 Maintains Outperform
01/28/2021 191.45% Truist Securities → $61 Initiates Coverage On → Buy
11/10/2020 — Keybanc Initiates Coverage On → Sector Weight
11/04/2020 100.67% BTIG $38 → $42 Maintains Buy
11/03/2020 91.11% Needham $37 → $40 Maintains Buy
11/03/2020 91.11% SVB Leerink $37 → $40 Maintains Outperform
09/09/2020 67.22% Morgan Stanley → $35 Initiates Coverage On → Underweight
07/31/2020 76.78% SVB Leerink $32 → $37 Maintains Outperform
07/31/2020 76.78% Needham $30 → $37 Maintains Buy
05/07/2020 52.89% SVB Leerink $29 → $32 Maintains Outperform
02/26/2020 43.33% Needham $34 → $30 Maintains Buy
07/31/2019 — Lake Street Initiates Coverage On → Buy
07/02/2019 57.67% Needham → $33 Initiates Coverage On → Buy
11/29/2018 — Janney Montgomery Scott Downgrades Buy → Neutral
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
10/23/2023 52.89% 高盛 $37→$32 维护 买
10/20/2023 52.89% 高盛 $37→$32 维护 买
2023年10月10日 62.45% 斯蒂芬斯公司 →$34 重申 超重→超重
08/09/2023 9.89% 摩根士丹利 $22→$23 维护 体重不足
08/09/2023 67.22% 李约瑟 $34→$35 维护 买
05/08/2023 43.33% 斯蒂芬斯公司 →$30 重申 →超重
02/23/2023 62.45% 李约瑟 $33→$34 维护 买
01/18/2023 - 雷蒙德·詹姆斯 评级下调 跑赢→市场表现
01/05/2023 57.67% 加拿大丰业银行 →$33 开始承保 →板块跑赢大盘
11/04/2022 5.11% 摩根士丹利 $23→$22 维护 体重不足
11/04/2022 29% 雷蒙德·詹姆斯 $31→$27 维护 跑赢大盘
11/03/2022 57.67% 李约瑟 $31→$33 维护 买
11/03/2022 67.22% SVB Leerink $30→$35 维护 跑赢大盘
08/04/2022 48.11% 雷蒙德·詹姆斯 $30→$31 维护 跑赢大盘
08/03/2022 48.11% 李约瑟 $26→$31 维护 买
05/05/2022 43.33% 斯蒂芬斯公司 $44→$30 维护 超重
05/04/2022 9.89% 摩根士丹利 $25→$23 维护 体重不足
05/04/2022 43.33% 雷蒙德·詹姆斯 $34→$30 维护 跑赢大盘
05/04/2022 24.22% 李约瑟 $31→$26 维护 买
03/15/2022 48.11% 李约瑟 $35→$31 维护 买
03/02/2022 110.22% 斯蒂芬斯公司 $52→$44 维护 超重
03/01/2022 62.45% 雷蒙德·詹姆斯 $62→$34 维护 跑赢大盘
03/01/2022 91.11% SVB Leerink $45→$40 维护 跑赢大盘
01/07/2022 148.45% 斯蒂芬斯公司 →$52 开始承保 →超重
2021年11月10日 196.23% 雷蒙德·詹姆斯 $50→$62 维护 跑赢大盘
07/30/2021 100.67% 摩根士丹利 $45→$42 维护 体重不足
07/30/2021 162.78% 李约瑟 $54→$55 维护 买
07/30/2021 186.67% SVB Leerink $55→$60 维护 跑赢大盘
07/14/2021 162.78% SVB Leerink $65→$55 维护 跑赢大盘
2021/06/28 138.89% 雷蒙德·詹姆斯 $45→$50 维护 跑赢大盘
2021/06/15 115% 雷蒙德·詹姆斯 →$45 开始承保 →跑赢大盘
2021/05/18 162.78% Truist证券 $84→$55 维护 买
2021/05/12 115% 摩根士丹利 $65→$45 维护 体重不足
2021/11/05 210.56% SVB Leerink $75→$65 维护 跑赢大盘
2021/11/05 158% 李约瑟 $88→$54 维护 买
02/22/2021 210.56% 摩根士丹利 $35→$65 维护 体重不足
02/19/2021 210.56% 摩根士丹利 $35→$65 维护 体重不足
02/18/2021 306.12% SVB Leerink $83→$85 维护 跑赢大盘
02/08/2021 296.56% SVB Leerink $40→$83 维护 跑赢大盘
2021年1月28日 191.45% Truist证券 →$61 开始承保 →购买
11/10/2020 - KeyBanc 开始承保 →行业权重
11/04/2020 100.67% BTIG $38→$42 维护 买
11/03/2020 91.11% 李约瑟 $37→$40 维护 买
11/03/2020 91.11% SVB Leerink $37→$40 维护 跑赢大盘
09/09/2020 67.22% 摩根士丹利 →$35 开始承保 →减持
07/31/2020 76.78% SVB Leerink $32→$37 维护 跑赢大盘
07/31/2020 76.78% 李约瑟 $30→$37 维护 买
05/07/2020 52.89% SVB Leerink $29→$32 维护 跑赢大盘
02/26/2020 43.33% 李约瑟 $34→$30 维护 买
2019年07月31日 - 莱克街 开始承保 →购买
2019年07月02日 57.67% 李约瑟 →$33 开始承保 →购买
2018年11月29日 - 詹尼·蒙哥马利·斯科特 评级下调 购买→中性

What is the target price for Veracyte (VCYT)?

Veracyte的目标价是多少？

The latest price target for Veracyte (NASDAQ: VCYT) was reported by Goldman Sachs on October 23, 2023. The analyst firm set a price target for $32.00 expecting VCYT to rise to within 12 months (a possible 52.89% upside). 13 analyst firms have reported ratings in the last year.

高盛于2023年10月23日报道了Veracyte(纳斯达克：VCYT)的最新目标价。这家分析公司将目标价定为32.00美元，预计VCyT将在12个月内上涨(可能上涨52.89%)。过去一年，有13家分析公司公布了评级。

What is the most recent analyst rating for Veracyte (VCYT)?

Veracyte的最新分析师评级是什么？

The latest analyst rating for Veracyte (NASDAQ: VCYT) was provided by Goldman Sachs, and Veracyte maintained their buy rating.

高盛对Veracyte(纳斯达克代码：VCYT)的最新分析师评级为买入，Veracyte维持买入评级。

When is the next analyst rating going to be posted or updated for Veracyte (VCYT)?

Veracyte的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Veracyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Veracyte was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Veracyte的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Veracyte的上一次评级是在2023年10月23日提交的，所以你应该预计下一次评级将在2024年10月23日左右的某个时候公布。

Is the Analyst Rating Veracyte (VCYT) correct?

分析师评级Veracyte(VCyT)正确吗？

While ratings are subjective and will change, the latest Veracyte (VCYT) rating was a maintained with a price target of $37.00 to $32.00. The current price Veracyte (VCYT) is trading at is $20.93, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Veracyte(VCyT)评级维持不变，目标价在37.00美元至32.00美元之间。Veracyte目前的交易价格为20.93美元，超出了分析师的预测区间。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发